HEM Pharma's Largest Shareholder Ji Josef's Shareholding Ratio in HEM Pharma Shares Decreased by 0.07%... Total Ownership Ratio at 26.65%

HEM Pharma (376270), a biotech company listed on KOSDAQ since 2016, reported on June 22 that its largest shareholder, Ji Josef, saw a 0.07 percentage point decline in shareholding ratio due to an increase in total issued shares, despite a 6,000-share increase from stock purchase rights. Total ownership stands at 26.65%, with Ji Josef holding 11.94%, Bilhelm Holzjapfel 11.18%, and Park So-Young 0.72%. Joint ownership agreements with Bilhelm and Park, all set to expire on May 31, 2024, and other share transactions, including Kim Bong-jun's 6,000-share increase, were disclosed. The stock closed at 47,750 won on June 22, down 6.37% from the previous day.